Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira L Kraft

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood|November 25, 2020
Identifying potential germline variants from sequencing hematopoietic malignanciesIra L Kraft, Lucy A Godley
Hematology. American Society of Hematology. Education Program|December 4, 2020
Identifying potential germline variants from sequencing hematopoietic malignanciesIra L Kraft, Lucy A Godley
Dalton Transactions (Cambridge, England : 2003)|December 22, 2009
Electron rich bidentate phosphinimine-imine ligands: synthesis and reactivity of late transition metal complexesChristopher J Wallis, Ira L Kraft, Brian O Patrick, et al.
Blood Advances|October 27, 2020
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignanciesAmy M Trottier, Lawrence J Druhan, Ira L Kraft, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2023
Sequential tumor molecular profiling identifies likely germline variantsIra L Kraft, Hatice Basdag, Ashwin Koppayi, et al.
Endocrine-Related Cancer|December 11, 2025
The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid CarcinomaIra L Kraft, Srivandana Akshintala, Andrea Gross, et al.
Cancer Research|July 27, 2013
KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitorsAmie S Corbin, Thomas O'Hare, Zhimin Gu, et al.
Haematologica|February 9, 2018
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphomaHaneen Shalabi, Ira L Kraft, Hao-Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2019
Modulation of Target Antigen Density Improves CAR T-cell Functionality and PersistenceSneha Ramakrishna, Steven L Highfill, Zachary Walsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with VandetanibIra L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|November 25, 2020
Identifying potential germline variants from sequencing hematopoietic malignanciesIra L Kraft, Lucy A Godley
Hematology. American Society of Hematology. Education Program|December 4, 2020
Identifying potential germline variants from sequencing hematopoietic malignanciesIra L Kraft, Lucy A Godley
Dalton Transactions (Cambridge, England : 2003)|December 22, 2009
Electron rich bidentate phosphinimine-imine ligands: synthesis and reactivity of late transition metal complexesChristopher J Wallis, Ira L Kraft, Brian O Patrick, et al.
Blood Advances|October 27, 2020
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignanciesAmy M Trottier, Lawrence J Druhan, Ira L Kraft, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2023
Sequential tumor molecular profiling identifies likely germline variantsIra L Kraft, Hatice Basdag, Ashwin Koppayi, et al.
Endocrine-Related Cancer|December 11, 2025
The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid CarcinomaIra L Kraft, Srivandana Akshintala, Andrea Gross, et al.
Cancer Research|July 27, 2013
KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitorsAmie S Corbin, Thomas O'Hare, Zhimin Gu, et al.
Haematologica|February 9, 2018
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphomaHaneen Shalabi, Ira L Kraft, Hao-Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2019
Modulation of Target Antigen Density Improves CAR T-cell Functionality and PersistenceSneha Ramakrishna, Steven L Highfill, Zachary Walsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with VandetanibIra L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pageof 2